Cargando…
Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients
PURPOSE: Identification of vulnerable plaques remains crucial for better cardiovascular risk assessment. At least 20% of inflammatory cells within unstable (vulnerable) plaques comprise T lymphocytes, which contain receptors for interleukin-2 (IL-2); those receptors can be identified by scintigraphy...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315638/ https://www.ncbi.nlm.nih.gov/pubmed/22237843 http://dx.doi.org/10.1007/s00259-011-2026-3 |
_version_ | 1782228266034135040 |
---|---|
author | Opalinska, Marta Stompor, Tomasz Pach, Dorota Mikolajczak, Renata Fedak, Danuta Krzanowski, Marcin Rakowski, Tomasz Sowa-Staszczak, Anna Glowa, Boguslaw Garnuszek, Piotr Maurin, Michał Karczmarczyk, Urszula Sulowicz, Władysław Hubalewska-Dydejczyk, Alicja |
author_facet | Opalinska, Marta Stompor, Tomasz Pach, Dorota Mikolajczak, Renata Fedak, Danuta Krzanowski, Marcin Rakowski, Tomasz Sowa-Staszczak, Anna Glowa, Boguslaw Garnuszek, Piotr Maurin, Michał Karczmarczyk, Urszula Sulowicz, Władysław Hubalewska-Dydejczyk, Alicja |
author_sort | Opalinska, Marta |
collection | PubMed |
description | PURPOSE: Identification of vulnerable plaques remains crucial for better cardiovascular risk assessment. At least 20% of inflammatory cells within unstable (vulnerable) plaques comprise T lymphocytes, which contain receptors for interleukin-2 (IL-2); those receptors can be identified by scintigraphy with radiolabelled IL-2.The aim of this study was to identify the “inflamed” (vulnerable) plaques by scintigraphy using IL-2 labelled with (99m)Tc in the selected, high cardiovascular risk group of end-stage renal disease (ESRD) patients. METHODS: A total of 28 patients (18 men, 10 women, aged 55.2 ± 9.6 years, 17 on peritoneal dialysis, 11 on haemodialysis) underwent common carotid artery (CCA) scintigraphy with the use of (99m)Tc-hydrazinonicotinamide (HYNIC)-IL-2. In all cases, ultrasound examination of the CCA was performed and levels of selected proinflammatory factors, atherogenic markers and calcium-phosphate balance parameters were measured. Finally, the target to non-target (T/nT) ratio of IL-2 uptake in atherosclerotic plaques with intima-media thickness (IMT), classic cardiovascular risk factors and concentrations of the measured factors were compared. RESULTS: Increased (99m)Tc-HYNIC-IL-2 uptake in atherosclerotic plaques in 38/41 (91%) cases was detected. The median T/nT ratio of focal (99m)Tc-HYNIC-IL-2 uptake in atherosclerotic plaques was 2.35 (range 1.23–3.63). The mean IMT value on the side of plaques assessed by scintigraphy was 0.79 ± 0.18 mm (median 0.8, range 0.5–1.275). Correlations between T/nT ratio and homocysteine (R = 0.22, p = 0.037), apolipoprotein B (apoB) (R = 0.31, p = 0.008), apoB to apoA-I ratio (R = 0.29, p = 0.012) and triglyceride concentration (R = 0.26, p = 0.021) were detected. A lower T/nT ratio in patients with better parameters of nutritional status (haemoglobin, albumin, adiponectin) in comparison with patients with worse nutritional parameters (3.20 ± 0.5 vs 2.16 ± 0.68, p = 0.025) was revealed as well as a difference between values of T/nT ratio in groups of patients with values of apoB, soluble CD40 ligand and asymmetric dimethylarginine above and below median (3.18 ± 0.52 vs 2.16 ± 0.68, p = 0.031). No statistically significant association was found between T/nT ratio and mean value of either IMT or classic cardiovascular risk factors. CONCLUSION: Scintigraphy with the use of (99m)Tc-HYNIC-IL-2 can be a tool for inflamed atherosclerotic (vulnerable) plaque visualization within CCA in ESRD patients. Quantitative results of carotid artery scintigraphy with (99m)Tc-HYNIC-IL-2 correlate with serum concentration of selected cardiovascular risk markers. |
format | Online Article Text |
id | pubmed-3315638 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-33156382012-04-05 Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients Opalinska, Marta Stompor, Tomasz Pach, Dorota Mikolajczak, Renata Fedak, Danuta Krzanowski, Marcin Rakowski, Tomasz Sowa-Staszczak, Anna Glowa, Boguslaw Garnuszek, Piotr Maurin, Michał Karczmarczyk, Urszula Sulowicz, Władysław Hubalewska-Dydejczyk, Alicja Eur J Nucl Med Mol Imaging Original Article PURPOSE: Identification of vulnerable plaques remains crucial for better cardiovascular risk assessment. At least 20% of inflammatory cells within unstable (vulnerable) plaques comprise T lymphocytes, which contain receptors for interleukin-2 (IL-2); those receptors can be identified by scintigraphy with radiolabelled IL-2.The aim of this study was to identify the “inflamed” (vulnerable) plaques by scintigraphy using IL-2 labelled with (99m)Tc in the selected, high cardiovascular risk group of end-stage renal disease (ESRD) patients. METHODS: A total of 28 patients (18 men, 10 women, aged 55.2 ± 9.6 years, 17 on peritoneal dialysis, 11 on haemodialysis) underwent common carotid artery (CCA) scintigraphy with the use of (99m)Tc-hydrazinonicotinamide (HYNIC)-IL-2. In all cases, ultrasound examination of the CCA was performed and levels of selected proinflammatory factors, atherogenic markers and calcium-phosphate balance parameters were measured. Finally, the target to non-target (T/nT) ratio of IL-2 uptake in atherosclerotic plaques with intima-media thickness (IMT), classic cardiovascular risk factors and concentrations of the measured factors were compared. RESULTS: Increased (99m)Tc-HYNIC-IL-2 uptake in atherosclerotic plaques in 38/41 (91%) cases was detected. The median T/nT ratio of focal (99m)Tc-HYNIC-IL-2 uptake in atherosclerotic plaques was 2.35 (range 1.23–3.63). The mean IMT value on the side of plaques assessed by scintigraphy was 0.79 ± 0.18 mm (median 0.8, range 0.5–1.275). Correlations between T/nT ratio and homocysteine (R = 0.22, p = 0.037), apolipoprotein B (apoB) (R = 0.31, p = 0.008), apoB to apoA-I ratio (R = 0.29, p = 0.012) and triglyceride concentration (R = 0.26, p = 0.021) were detected. A lower T/nT ratio in patients with better parameters of nutritional status (haemoglobin, albumin, adiponectin) in comparison with patients with worse nutritional parameters (3.20 ± 0.5 vs 2.16 ± 0.68, p = 0.025) was revealed as well as a difference between values of T/nT ratio in groups of patients with values of apoB, soluble CD40 ligand and asymmetric dimethylarginine above and below median (3.18 ± 0.52 vs 2.16 ± 0.68, p = 0.031). No statistically significant association was found between T/nT ratio and mean value of either IMT or classic cardiovascular risk factors. CONCLUSION: Scintigraphy with the use of (99m)Tc-HYNIC-IL-2 can be a tool for inflamed atherosclerotic (vulnerable) plaque visualization within CCA in ESRD patients. Quantitative results of carotid artery scintigraphy with (99m)Tc-HYNIC-IL-2 correlate with serum concentration of selected cardiovascular risk markers. Springer-Verlag 2012-01-12 2012 /pmc/articles/PMC3315638/ /pubmed/22237843 http://dx.doi.org/10.1007/s00259-011-2026-3 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Original Article Opalinska, Marta Stompor, Tomasz Pach, Dorota Mikolajczak, Renata Fedak, Danuta Krzanowski, Marcin Rakowski, Tomasz Sowa-Staszczak, Anna Glowa, Boguslaw Garnuszek, Piotr Maurin, Michał Karczmarczyk, Urszula Sulowicz, Władysław Hubalewska-Dydejczyk, Alicja Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients |
title | Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients |
title_full | Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients |
title_fullStr | Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients |
title_full_unstemmed | Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients |
title_short | Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients |
title_sort | imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)tc-hynic-il-2 scintigraphy in end-stage renal disease patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315638/ https://www.ncbi.nlm.nih.gov/pubmed/22237843 http://dx.doi.org/10.1007/s00259-011-2026-3 |
work_keys_str_mv | AT opalinskamarta imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients AT stomportomasz imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients AT pachdorota imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients AT mikolajczakrenata imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients AT fedakdanuta imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients AT krzanowskimarcin imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients AT rakowskitomasz imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients AT sowastaszczakanna imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients AT glowaboguslaw imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients AT garnuszekpiotr imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients AT maurinmichał imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients AT karczmarczykurszula imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients AT sulowiczwładysław imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients AT hubalewskadydejczykalicja imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients |